Favourable outcome in a pregnancy with concomitant maternal and fetal osteogenesis imperfecta associated with a novel COL1A2 mutation [7]

Prenatal Diagnosis

Volumn 26, Issue 2, 2006, Pages 188-190

  Chen, Chih Ping ^a,b,c   Su, Yi Ning ^d   Lin, Shuan Pei ^a   Lin, Mei Ling ^a   Wang, Wayseen ^a  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAMNESIS; CASE REPORT; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; LETTER; OSTEOGENESIS IMPERFECTA; PREGNANCY; PRIORITY JOURNAL;

ADULT; CESAREAN SECTION; COLLAGEN; FEMALE; GENETIC COUNSELING; HUMANS; INFANT, NEWBORN; MUTATION; OSTEOGENESIS IMPERFECTA; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND;

EID: 33344479145     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/pd.1375     Document Type: Letter

References (14)

1. Chamberlain JR, Schwarze U, Wang P-R, et al. 2004. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 303: 1198-1201.
2. Forlino A, D'Amato E, Valli M, et al. 1997. Phenotypic comparison of an osteogenesis imperfecta type IV proband with a de novo α2(I) Gly992 → Ser substitution in type I collagen and an unrelated patient with an identical mutation. Biochem Mol Med 62: 26-35.
3. King D, Jarjoura D, McEwen HA, Askew MJ. 2005. Growth hormone injections improve bone quality in a mouse model of osteogenesis imperfecta. J Bone Miner Res 20: 987-993.
4. Körkkö J, Ala-Kokko L, De Paepe A, et al. 1998. Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type 1: identification of common sequences of null-allele mutations. Am J Hum Genet 62: 98-110.
5. Le Blanc K, Götherström C, Ringdén O, et al. 2005. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79: 1607-1614.
6. Millington-Ward S, McMahon HP, Farrar GJ. 2005. Emerging therapeutic approaches for osteogenesis imperfecta. Trends Mol Med 11: 299-305.
7. Nuytinck L, Sayli BS, Karen W, De Paepe A. 1999. Prenatal diagnosis of osteogenesis imperfecta type I by COL1A1 null-allele testing. Prenat Diagn 19: 873-875.
8. Rauch F, Glorieux FH. 2004. Osteogenesis imperfecta. Lancet 363: 1377-1385.
9. Rauch F, Glorieux FH. 2005. Bisphosphonate treatment in osteogenesis imperfecta: which drug, for whom, for how long? Ann Med 37: 295-302.
10. Ries L, Frydman M, Barkai G, Goldman B, Friedman E. 2000. Prenatal diagnosis of a novel COL1A1 mutation in osteogenesis imperfecta type I carried through full term pregnancy. Prenat Diagn 20: 876-880.
11. Sykes B, Ogilvie D, Wordsworth P, et al. 1990. Consistent linkage of dominantly inherited osteogenesis imperfecta to the type 1 collagen loci: COL1A1 and COL1A2. Am J Hum Genet 46: 293-307.
12. Willing MC, Deschenes SP, Scott DA, et al. 1994. Osteogenesis imperfecta type 1: molecular heterogeneity for COL1A1 null alleles of type 1 collagen. Am J Hum Genet 55: 638-647.
13. Willing MC, Deschenes SP, Slayton RL, Roberts EJ. 1996. Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type 1 cell strains. Am J Hum Genet 59: 799-809.
14. Zolezzi F, Valli M, Clementi M, et al. 1997. Mutation producing alternative splicing of exon 26 in the COL1A2 gene causes type IV osteogenesis imperfecta with intrafamilial clinical variability. Am J Med Genet 71: 366-370.